Phenyltoloxamine

Jump to: navigation, search
Phenyltoloxamine.png
Phenyltoloxamine
Systematic (IUPAC) name
N,N-dimethyl-2-(α-phenyl-O-tolyloxy)ethylamine
Identifiers
CAS number 92-12-6
ATC code  ?
PubChem 7077
Chemical data
Formula C17H21NO 
Mol. mass 255.359
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status

OTC(US)

Routes oral

WikiDoc Resources for

Phenyltoloxamine

Articles

Most recent articles on Phenyltoloxamine

Most cited articles on Phenyltoloxamine

Review articles on Phenyltoloxamine

Articles on Phenyltoloxamine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Phenyltoloxamine

Images of Phenyltoloxamine

Photos of Phenyltoloxamine

Podcasts & MP3s on Phenyltoloxamine

Videos on Phenyltoloxamine

Evidence Based Medicine

Cochrane Collaboration on Phenyltoloxamine

Bandolier on Phenyltoloxamine

TRIP on Phenyltoloxamine

Clinical Trials

Ongoing Trials on Phenyltoloxamine at Clinical Trials.gov

Trial results on Phenyltoloxamine

Clinical Trials on Phenyltoloxamine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Phenyltoloxamine

NICE Guidance on Phenyltoloxamine

NHS PRODIGY Guidance

FDA on Phenyltoloxamine

CDC on Phenyltoloxamine

Books

Books on Phenyltoloxamine

News

Phenyltoloxamine in the news

Be alerted to news on Phenyltoloxamine

News trends on Phenyltoloxamine

Commentary

Blogs on Phenyltoloxamine

Definitions

Definitions of Phenyltoloxamine

Patient Resources / Community

Patient resources on Phenyltoloxamine

Discussion groups on Phenyltoloxamine

Patient Handouts on Phenyltoloxamine

Directions to Hospitals Treating Phenyltoloxamine

Risk calculators and risk factors for Phenyltoloxamine

Healthcare Provider Resources

Symptoms of Phenyltoloxamine

Causes & Risk Factors for Phenyltoloxamine

Diagnostic studies for Phenyltoloxamine

Treatment of Phenyltoloxamine

Continuing Medical Education (CME)

CME Programs on Phenyltoloxamine

International

Phenyltoloxamine en Espanol

Phenyltoloxamine en Francais

Business

Phenyltoloxamine in the Marketplace

Patents on Phenyltoloxamine

Experimental / Informatics

List of terms related to Phenyltoloxamine

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Phenyltoloxamine is an antihistamine with sedative and analgesic effects. It is a member of the ethanolamine class of antihistaminergic agents and a potent anticholinergic.

Common use

Phenyltoloxamine is widely used in preparations as an enhancing agent for some analgesics and antitussives (acetaminophen, codeine, hydrocodone). It is widely used in certain parts of the world as cough suppressant usually with codeine.

It also used to discourage abuse in certain opiate analgesics due its unpleasant side effects at high doses.

Adverse effects

Common adverse effects are those associated with most anticholinergics, effects are more pronounced in children and the elderly.

See also: anticholinergic

Availability

Phenyltoloxamine is available in most countries, though is rare in several western countries it remains widely used around the world, particularly in the developing world.

It is not a controlled substance; however some preparations contain opiates such as codeine or hydrocodone and are controlled, when used in preparations with acetaminophen is generally over the counter.

Phenyltoloxamine is sold under wide variety of preparations, brand names and dosages around the world:

  • Ed-Flex, Dologesic, Flextra-650, Novagesic, Phenylgesic - North America
  • Codipront - Europe/South America



Cost Effectiveness of Phenyltoloxamine

| group5 = Clinical Trials Involving Phenyltoloxamine | list5 = Ongoing Trials on Phenyltoloxamine at Clinical Trials.govTrial results on PhenyltoloxamineClinical Trials on Phenyltoloxamine at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Phenyltoloxamine | list6 = US National Guidelines Clearinghouse on PhenyltoloxamineNICE Guidance on PhenyltoloxamineNHS PRODIGY GuidanceFDA on PhenyltoloxamineCDC on Phenyltoloxamine


| group7 = Textbook Information on Phenyltoloxamine | list7 = Books and Textbook Information on Phenyltoloxamine


| group8 = Pharmacology Resources on Phenyltoloxamine | list8 = AND (Dose)}} Dosing of PhenyltoloxamineAND (drug interactions)}} Drug interactions with PhenyltoloxamineAND (side effects)}} Side effects of PhenyltoloxamineAND (Allergy)}} Allergic reactions to PhenyltoloxamineAND (overdose)}} Overdose information on PhenyltoloxamineAND (carcinogenicity)}} Carcinogenicity information on PhenyltoloxamineAND (pregnancy)}} Phenyltoloxamine in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Phenyltoloxamine


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Phenyltoloxamine | list9 = AND (pharmacogenomics)}} Genetics of PhenyltoloxamineAND (pharmacogenomics)}} Pharmacogenomics of PhenyltoloxamineAND (proteomics)}} Proteomics of Phenyltoloxamine


| group10 = Newstories on Phenyltoloxamine | list10 = Phenyltoloxamine in the newsBe alerted to news on PhenyltoloxamineNews trends on Phenyltoloxamine</small>


| group11 = Commentary on Phenyltoloxamine | list11 = Blogs on Phenyltoloxamine

| group12 = Patient Resources on Phenyltoloxamine | list12 = Patient resources on PhenyltoloxamineDiscussion groups on PhenyltoloxaminePatient Handouts on PhenyltoloxamineDirections to Hospitals Treating PhenyltoloxamineRisk calculators and risk factors for Phenyltoloxamine


| group13 = Healthcare Provider Resources on Phenyltoloxamine | list13 = Symptoms of PhenyltoloxamineCauses & Risk Factors for PhenyltoloxamineDiagnostic studies for PhenyltoloxamineTreatment of Phenyltoloxamine

| group14 = Continuing Medical Education (CME) Programs on Phenyltoloxamine | list14 = CME Programs on Phenyltoloxamine

| group15 = International Resources on Phenyltoloxamine | list15 = Phenyltoloxamine en EspanolPhenyltoloxamine en Francais

| group16 = Business Resources on Phenyltoloxamine | list16 = Phenyltoloxamine in the MarketplacePatents on Phenyltoloxamine

| group17 = Informatics Resources on Phenyltoloxamine | list17 = List of terms related to Phenyltoloxamine


}}


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox